FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Baxter Healthcare 0.9% Sodium Chloride Injection Recall

0.9% Sodium Chloride Injection USP, 250 mL VIAFLEX Container bag, Rx only, Baxter Healt…

Baxter Healthcare Corporation · Deerfield, IL

Risk level
Class II
Reported by FDA
Jul 19, 2017
Recall ID
D-0957-2017
Check your lot numberHow we source this data

Summary

Baxter Healthcare recalled 0.9% Sodium Chloride Injection starting Jul 6, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0957-2017 on Jul 19, 2017. Reason: Lack of Assurance of Sterility: Customer complaints for leaking bags. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: Customer complaints for leaking bags.

Product description

0.9% Sodium Chloride Injection USP, 250 mL VIAFLEX Container bag, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015; Distributed in Canada by Baxter Corporation, Toronto, Ontario, Canada, Product Code: 2B1322, NDC 0338-0049-02.

Lot numbers, UPCs & expiration codes

Lot: Y229153, Exp 09/30/18

Where it was sold

Nationwide in USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0957-2017
Classification
Class II
Status
Terminated
Recall initiated
Jul 6, 2017
FDA report date
Jul 19, 2017
Quantity
131,904 bags
Recall type
Voluntary: Firm initiated
Recalling firm
Baxter Healthcare Corporation

Original FDA data

Every field from FDA enforcement report D-0957-2017, exactly as published.

Show all FDA fields
City
Deerfield
State
IL
Status
Terminated
Country
United States
Event ID
77678
Address
1 Baxter Pkwy
Code information
Lot: Y229153, Exp 09/30/18
Postal code
60015-4625
Report date
Jul 19, 2017
Product type
Drugs
Recall number
D-0957-2017
Classification
Class II
Recalling firm
Baxter Healthcare Corporation
Product quantity
131,904 bags
Termination date
Apr 29, 2020
Reason for recall
Lack of Assurance of Sterility: Customer complaints for leaking bags.
Voluntary / mandated
Voluntary: Firm initiated
Product description
0.9% Sodium Chloride Injection USP, 250 mL VIAFLEX Container bag, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015; Distributed in Canada by Baxter Corporation, Toronto, Ontario, Canada, Product Code: 2B1322, NDC 0338-0049-02.
Distribution pattern
Nationwide in USA
Recall initiation date
Jul 6, 2017
Initial firm notification
Letter
Center classification date
Jul 7, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0957-2017, published Jul 19, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls